| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/25/2023 | -4.84% | Morgan Stanley | $13 → $12 | Maintains | Underweight |
| 07/26/2023 | 3.09% | Morgan Stanley | $13 → $13 | Reiterates | Underweight → Underweight |
| 07/26/2023 | -12.77% | Credit Suisse | $9 → $11 | Maintains | Underperform |
| 04/26/2023 | 3.09% | Morgan Stanley | $11 → $13 | Maintains | Underweight |
| 10/26/2022 | -20.7% | Citigroup | $15 → $10 | Maintains | Sell |
| 10/18/2022 | 3.09% | Credit Suisse | $14 → $13 | Maintains | Underperform |
| 10/17/2022 | -12.77% | Morgan Stanley | $14 → $11 | Maintains | Underweight |
| 08/17/2022 | 11.02% | Credit Suisse | → $14 | Initiates Coverage On | → Underperform |
| 07/27/2022 | 11.02% | Morgan Stanley | $13 → $14 | Maintains | Underweight |
| 07/14/2022 | 11.02% | JP Morgan | $16 → $14 | Maintains | Underweight |
| 04/22/2022 | 3.09% | Morgan Stanley | $15 → $13 | Maintains | Underweight |
| 04/22/2022 | 18.95% | Citigroup | $17 → $15 | Maintains | Sell |
| 09/23/2021 | 34.81% | Morgan Stanley | → $17 | Initiates Coverage On | → Underweight |
| 02/04/2021 | 42.74% | Morgan Stanley | → $18 | Downgrades | Equal-Weight → Underweight |
| 01/27/2021 | 58.6% | Morgan Stanley | $22 → $20 | Maintains | Equal-Weight |
| 01/27/2021 | 58.6% | Credit Suisse | $23 → $20 | Downgrades | Outperform → Neutral |
| 01/22/2021 | 74.46% | Morgan Stanley | $24 → $22 | Maintains | Equal-Weight |
| 12/16/2020 | 90.33% | Morgan Stanley | $17 → $24 | Maintains | Equal-Weight |
| 10/13/2020 | 34.81% | Morgan Stanley | $14 → $17 | Maintains | Equal-Weight |
| 07/29/2020 | 66.53% | Credit Suisse | $23 → $21 | Maintains | Outperform |
| 07/24/2020 | 58.6% | JP Morgan | $23 → $20 | Downgrades | Neutral → Underweight |
| 04/27/2020 | 74.46% | Credit Suisse | $43 → $22 | Maintains | Outperform |
| 04/09/2020 | 3.09% | Citigroup | → $13 | Reinstates | → Sell |
| 04/02/2020 | 98.26% | JP Morgan | $33 → $25 | Maintains | Neutral |
| 03/25/2020 | 50.67% | Morgan Stanley | $33 → $19 | Maintains | Equal-Weight |
| 01/29/2020 | 161.7% | Morgan Stanley | $34 → $33 | Maintains | Equal-Weight |
| 01/27/2020 | 169.63% | Morgan Stanley | → $34 | Reinstates | → Equal-Weight |
| 11/12/2019 | — | JP Morgan | Upgrades | Underweight → Neutral | |
| 10/30/2019 | 145.84% | JP Morgan | → $31 | Downgrades | Neutral → Underweight |
| 10/30/2019 | 241% | Credit Suisse | $42 → $43 | Maintains | Outperform |
| 04/11/2019 | 233.07% | Credit Suisse | → $42 | Initiates Coverage On | → Outperform |
What is the target price for Xerox Holdings (XRX)?
The latest price target for Xerox Holdings (NASDAQ: XRX) was reported by Morgan Stanley on October 25, 2023. The analyst firm set a price target for $12.00 expecting XRX to fall to within 12 months (a possible -4.84% downside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Xerox Holdings (XRX)?
The latest analyst rating for Xerox Holdings (NASDAQ: XRX) was provided by Morgan Stanley, and Xerox Holdings maintained their underweight rating.
When is the next analyst rating going to be posted or updated for Xerox Holdings (XRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Xerox Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Xerox Holdings was filed on October 25, 2023 so you should expect the next rating to be made available sometime around October 25, 2024.
Is the Analyst Rating Xerox Holdings (XRX) correct?
While ratings are subjective and will change, the latest Xerox Holdings (XRX) rating was a maintained with a price target of $13.00 to $12.00. The current price Xerox Holdings (XRX) is trading at is $12.61, which is out of the analyst's predicted range.